DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Otamixaban is an investigational drug.
There have been 5 clinical trials for Otamixaban. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2010.
The most common disease conditions in clinical trials are Acute Coronary Syndrome, Myocardial Infarction, and Infarction. The leading clinical trial sponsors are Sanofi and [disabled in preview].
Recent Clinical Trials for Otamixaban
|Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild and Moderate Hepatic Impairment||Sanofi||Phase 1|
|Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy||Sanofi||Phase 3|
|Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild, Moderate and Severe Renal Impairment||Sanofi||Phase 1|